Equities

Gan & Lee Pharmaceuticals

603087:SHH

Gan & Lee Pharmaceuticals

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)48.42
  • Today's Change-1.26 / -2.54%
  • Shares traded14.16m
  • 1 Year change+0.62%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue2,6081,7123,612
OPERATING EXPENSES
Cost of revenue total725406396
Selling, general and admin. expenses, total1,1461,3651,297
Depreciation/amortization989892
Unusual expense(income)12400.00
Other operating expenses, total(23)(45)(43)
Total operating expense2,2932,2811,913
Operating income315(569)1,699
Other, net(8.31)(7.93)(1.2)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes306(582)1,696
Provision for income taxes(34)(143)243
Net income after taxes340(440)1,453
Minority interest(0.16)0.000.00
Net income before extra. Items340(440)1,453
Total extraordinary items------
Net income340(440)1,453
Inc.avail. to common excl. extra. Items340(440)1,453
Inc.avail. to common incl. extra. Items340(440)1,453
EPS RECONCILIATION
Basic/primary weighted average shares567562562
Basic/primary eps excl. extra items0.60(0.78)2.59
Basic/primary eps incl. extra items0.60(0.78)2.59
Dilution adjustment------
Diluted weighted average shares567562562
Diluted eps excl. extra items0.60(0.78)2.59
Diluted eps incl. extra items0.60(0.78)2.59
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.2000.30
Gross dividend - common stock1190168
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.550.780.96
SUPPLEMENTAL INCOME
Depreciation, supplemental209185173
Total special items13461.70
NORMALISED INCOME
Normalized income before taxes319(536)1,698
Effect of special items on income taxes4.56160.24
Income tax excluding impact of special items(30)(127)244
Normalized income after tax349(410)1,454
Normalized income avail. to common349(410)1,454
Basic normalized EPS0.61(0.73)2.59
Diluted normalized EPS0.61(0.73)2.59
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.